These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25751608)

  • 1. Acceptability of live attenuated influenza vaccine by vaccine providers in Quebec, Canada.
    Dubé E; Gagnon D; Kiely M; Boulianne N; Landry M
    Hum Vaccin Immunother; 2015; 11(4):956-60. PubMed ID: 25751608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza immunization of chronically ill children in pediatric tertiary care hospitals.
    Dubé E; Gagnon D; Huot C; Paré R; Jacques S; Kossowski A; Quach C; Landry M
    Hum Vaccin Immunother; 2014; 10(10):2935-41. PubMed ID: 25483460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany.
    Falkenhorst G; Harder T; Remschmidt C; Terhardt M; Zepp F; Ledig T; Wicker S; Keller-Stanislawski B; Mertens T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1557-64. PubMed ID: 24170085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)?
    Merckx J; McCormack D; Quach C
    Vaccine; 2016 Feb; 34(6):750-6. PubMed ID: 26752064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccination rates in children decline when the live attenuated influenza vaccine is not recommended.
    Fogel B; Hicks S
    Vaccine; 2017 Sep; 35(39):5278-5282. PubMed ID: 28760609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel.
    Wang Z; Tobler S; Roayaei J; Eick A
    JAMA; 2009 Mar; 301(9):945-53. PubMed ID: 19255113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parents' preferences for seasonal influenza vaccine for their children in Japan.
    Shono A; Kondo M
    Vaccine; 2014 Sep; 32(39):5071-6. PubMed ID: 25063570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.
    Coelingh K; Olajide IR; MacDonald P; Yogev R
    Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
    Block SL; Toback SL; Yi T; Ambrose CS
    Clin Ther; 2009 Oct; 31(10):2140-7. PubMed ID: 19922885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.
    Ambrose CS; Wu X; Knuf M; Wutzler P
    Vaccine; 2012 Jan; 30(5):886-92. PubMed ID: 22155144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinating high-risk children with the intranasal live-attenuated influenza vaccine: the Quebec experience.
    Quach C
    Paediatr Respir Rev; 2014 Dec; 15(4):340-7. PubMed ID: 25242731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.
    Kahn KE; Santibanez TA; Zhai Y; Singleton JA
    Vaccine; 2015 Sep; 33(39):5196-203. PubMed ID: 26238724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives from the Society for Pediatric Research: Decreased Effectiveness of the Live Attenuated Influenza Vaccine.
    Gill MA; Schlaudecker EP
    Pediatr Res; 2018 Jan; 83(1-1):31-40. PubMed ID: 28945700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
    Thommes EW; Ismaila A; Chit A; Meier G; Bauch CT
    BMC Infect Dis; 2015 Oct; 15():465. PubMed ID: 26503131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008-2014.
    Rodgers L; Pabst LJ; Chaves SS
    Vaccine; 2015 Jan; 33(1):22-4. PubMed ID: 25448098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.